vs
奎斯特诊断（DGX）与Ross Stores（ROST）财务数据对比。点击上方公司名可切换其他公司
Ross Stores的季度营收约是奎斯特诊断的1.9倍（$5.6B vs $2.9B），奎斯特诊断净利率更高（9.7% vs 9.1%，领先0.6%），Ross Stores同比增速更快（10.4% vs 9.2%），过去两年奎斯特诊断的营收复合增速更高（9.9% vs -3.6%）
奎斯特诊断是美国头部临床检验服务商，位列《财富》500强，业务覆盖美国、波多黎各、墨西哥及巴西，同时与全球范围内多家医院、诊所保持长期协作关系，为不同地区的客户提供专业临床检验相关服务。
Ross Stores, Inc.是美国知名折扣百货连锁集团，旗下核心品牌为Ross Dress for Less，总部位于加利福尼亚州都柏林，是美国规模最大的平价零售商。截至2024年7月，集团在全美43个州、华盛顿特区、波多黎各及关岛共运营1795家门店，暂未覆盖新英格兰地区及阿拉斯加，另拥有门店数超353家的折扣零售品牌DD's Discounts。
DGX vs ROST — 直观对比
营收规模更大
ROST
是对方的1.9倍
$2.9B
营收增速更快
ROST
高出1.3%
9.2%
净利率更高
DGX
高出0.6%
9.1%
两年增速更快
DGX
近两年复合增速
-3.6%
损益表 — Q1 FY2026 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $2.9B | $5.6B |
| 净利润 | $281.0M | $511.9M |
| 毛利率 | — | 28.0% |
| 营业利润率 | 15.4% | 11.6% |
| 净利率 | 9.7% | 9.1% |
| 营收同比 | 9.2% | 10.4% |
| 净利润同比 | 12.0% | 4.7% |
| 每股收益（稀释后） | $2.24 | $1.58 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DGXROST
| Q1 26 | $2.9B | — | ||
| Q4 25 | $2.8B | $5.6B | ||
| Q3 25 | $2.8B | $5.5B | ||
| Q2 25 | $2.8B | $5.0B | ||
| Q1 25 | $2.7B | $5.9B | ||
| Q4 24 | $2.6B | $5.1B | ||
| Q3 24 | $2.5B | $5.3B | ||
| Q2 24 | $2.4B | $4.9B |
净利润DGXROST
| Q1 26 | $281.0M | — | ||
| Q4 25 | $245.0M | $511.9M | ||
| Q3 25 | $245.0M | $508.0M | ||
| Q2 25 | $282.0M | $479.2M | ||
| Q1 25 | $220.0M | $586.8M | ||
| Q4 24 | $222.0M | $488.8M | ||
| Q3 24 | $226.0M | $527.1M | ||
| Q2 24 | $229.0M | $488.0M |
毛利率DGXROST
| Q1 26 | — | — | ||
| Q4 25 | 32.4% | 28.0% | ||
| Q3 25 | 33.7% | 27.6% | ||
| Q2 25 | 34.2% | 28.2% | ||
| Q1 25 | 32.5% | 26.5% | ||
| Q4 24 | 32.7% | 28.3% | ||
| Q3 24 | 32.6% | 28.3% | ||
| Q2 24 | 33.5% | 28.1% |
营业利润率DGXROST
| Q1 26 | 15.4% | — | ||
| Q4 25 | 13.8% | 11.6% | ||
| Q3 25 | 13.7% | 11.5% | ||
| Q2 25 | 15.9% | 12.2% | ||
| Q1 25 | 13.0% | 12.4% | ||
| Q4 24 | 13.8% | 11.9% | ||
| Q3 24 | 13.3% | 12.5% | ||
| Q2 24 | 14.8% | 12.2% |
净利率DGXROST
| Q1 26 | 9.7% | — | ||
| Q4 25 | 8.7% | 9.1% | ||
| Q3 25 | 8.7% | 9.2% | ||
| Q2 25 | 10.2% | 9.6% | ||
| Q1 25 | 8.3% | 9.9% | ||
| Q4 24 | 8.5% | 9.6% | ||
| Q3 24 | 9.1% | 10.0% | ||
| Q2 24 | 9.6% | 10.0% |
每股收益（稀释后）DGXROST
| Q1 26 | $2.24 | — | ||
| Q4 25 | $2.18 | $1.58 | ||
| Q3 25 | $2.16 | $1.56 | ||
| Q2 25 | $2.47 | $1.47 | ||
| Q1 25 | $1.94 | $1.79 | ||
| Q4 24 | $1.95 | $1.48 | ||
| Q3 24 | $1.99 | $1.59 | ||
| Q2 24 | $2.03 | $1.46 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $393.0M | $4.1B |
| 总债务越低越好 | $5.7B | $1.5B |
| 股东权益账面价值 | $7.7B | $5.9B |
| 总资产 | $16.7B | $15.4B |
| 负债/权益比越低杠杆越低 | 0.74× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资DGXROST
| Q1 26 | $393.0M | — | ||
| Q4 25 | $420.0M | $4.1B | ||
| Q3 25 | $432.0M | $3.8B | ||
| Q2 25 | $319.0M | $3.8B | ||
| Q1 25 | $188.0M | $4.7B | ||
| Q4 24 | $549.0M | $4.3B | ||
| Q3 24 | $764.0M | $4.7B | ||
| Q2 24 | $271.0M | $4.7B |
总债务DGXROST
| Q1 26 | $5.7B | — | ||
| Q4 25 | $5.2B | $1.5B | ||
| Q3 25 | $5.2B | $1.5B | ||
| Q2 25 | $5.2B | $1.5B | ||
| Q1 25 | $5.9B | $2.2B | ||
| Q4 24 | $5.6B | $2.2B | ||
| Q3 24 | $5.6B | $2.5B | ||
| Q2 24 | $3.8B | $2.5B |
股东权益DGXROST
| Q1 26 | $7.7B | — | ||
| Q4 25 | $7.2B | $5.9B | ||
| Q3 25 | $7.3B | $5.7B | ||
| Q2 25 | $7.2B | $5.6B | ||
| Q1 25 | $6.9B | $5.5B | ||
| Q4 24 | $6.8B | $5.3B | ||
| Q3 24 | $6.8B | $5.1B | ||
| Q2 24 | $6.6B | $4.9B |
总资产DGXROST
| Q1 26 | $16.7B | — | ||
| Q4 25 | $16.2B | $15.4B | ||
| Q3 25 | $16.2B | $14.5B | ||
| Q2 25 | $16.0B | $14.3B | ||
| Q1 25 | $15.8B | $14.9B | ||
| Q4 24 | $16.2B | $14.9B | ||
| Q3 24 | $16.1B | $14.7B | ||
| Q2 24 | $13.9B | $14.5B |
负债/权益比DGXROST
| Q1 26 | 0.74× | — | ||
| Q4 25 | 0.72× | 0.26× | ||
| Q3 25 | 0.71× | 0.26× | ||
| Q2 25 | 0.72× | 0.27× | ||
| Q1 25 | 0.85× | 0.40× | ||
| Q4 24 | 0.83× | 0.42× | ||
| Q3 24 | 0.83× | 0.48× | ||
| Q2 24 | 0.58× | 0.50× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $278.0M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | — | $617.8M |
| 自由现金流率自由现金流/营收 | — | 11.0% |
| 资本支出强度资本支出/营收 | 3.9% | 3.7% |
| 现金转化率经营现金流/净利润 | 0.99× | 1.62× |
| 过去12个月自由现金流最近4个季度 | — | $2.0B |
8季度趋势，按日历期对齐
经营现金流DGXROST
| Q1 26 | $278.0M | — | ||
| Q4 25 | $465.0M | $827.1M | ||
| Q3 25 | $563.0M | $668.4M | ||
| Q2 25 | $544.0M | $409.7M | ||
| Q1 25 | $314.0M | $882.6M | ||
| Q4 24 | $464.0M | $513.4M | ||
| Q3 24 | $356.0M | $592.1M | ||
| Q2 24 | $360.0M | $368.9M |
自由现金流DGXROST
| Q1 26 | — | — | ||
| Q4 25 | $307.0M | $617.8M | ||
| Q3 25 | $419.0M | $466.6M | ||
| Q2 25 | $436.0M | $202.3M | ||
| Q1 25 | $197.0M | $676.6M | ||
| Q4 24 | $341.0M | $333.0M | ||
| Q3 24 | $250.0M | $394.6M | ||
| Q2 24 | $268.0M | $232.7M |
自由现金流率DGXROST
| Q1 26 | — | — | ||
| Q4 25 | 10.9% | 11.0% | ||
| Q3 25 | 14.9% | 8.4% | ||
| Q2 25 | 15.8% | 4.1% | ||
| Q1 25 | 7.4% | 11.4% | ||
| Q4 24 | 13.0% | 6.6% | ||
| Q3 24 | 10.0% | 7.5% | ||
| Q2 24 | 11.2% | 4.8% |
资本支出强度DGXROST
| Q1 26 | 3.9% | — | ||
| Q4 25 | 5.6% | 3.7% | ||
| Q3 25 | 5.1% | 3.6% | ||
| Q2 25 | 3.9% | 4.2% | ||
| Q1 25 | 4.4% | 3.5% | ||
| Q4 24 | 4.7% | 3.6% | ||
| Q3 24 | 4.3% | 3.7% | ||
| Q2 24 | 3.8% | 2.8% |
现金转化率DGXROST
| Q1 26 | 0.99× | — | ||
| Q4 25 | 1.90× | 1.62× | ||
| Q3 25 | 2.30× | 1.32× | ||
| Q2 25 | 1.93× | 0.85× | ||
| Q1 25 | 1.43× | 1.50× | ||
| Q4 24 | 2.09× | 1.05× | ||
| Q3 24 | 1.58× | 1.12× | ||
| Q2 24 | 1.57× | 0.76× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
